| Bioactivity | GSK8062 is a farnesoid X receptor (FXR) agonist with activity that improves compound development parameters. Analog 1c of GSK8062 showed a reduction in weight gain and serum glucose levels[1]. |
| CAS | 943549-47-1 |
| Formula | C30H23Cl2NO4 |
| Molar Mass | 532.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene |